Careful management can reduce the risk of bleeding in elderly patients receiving vitamin K antagonist (VKA) therapy

Author: Adis International Limited  

Publisher: Adis International

ISSN: 1172-0360

Source: Drugs & Therapy Perspectives, Vol.22, Iss.12, 2006-12, pp. : 23-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract